Patient Privacy. The parties hereto affirm their commitment to comply with federal and state law regarding the use and disclosure of protected health information. Each party agrees to comply with the applicable provisions of the Administrative Simplification section of the Health Insurance Portability and Accountability Act of 1996, as codified at 42 U.S.C. § 1320d through d-8 (“HIPAA”), and the requirements of any regulations promulgated thereunder including without limitation the federal privacy regulations as contained in 45 CFR Part 164 (the “Federal Security Regulations”). Each party will promptly report to the other any use of disclosure in violation of HIPAA, the Federal Privacy Regulations, or the Federal Security Regulations of a patient’s Protected Health Information which was previously disclosed to that party under this Agreement.
Patient Privacy. 9.1 Medco represents and warrants that it will perform all of its duties under this Agreement in compliance with all applicable federal, state, local and foreign laws and regulations and licensing requirements, including but not limited to those related to patient notification, authorization and consent, privacy of medical records and medical information. By way of example, Medco is required under the Standards adopted pursuant to the Health Insurance Portability and Accountability Act of 1996, either directly as a covered entity or in its role as a business associate of its health plan clients, to assure that protected health information (all as defined in such Standards) is used or disclosed only in accordance with such Standards.
Patient Privacy. Records Provider shall ensure that the Patient Records are transferred to Purinix in an irreversibly anonymous manner. If and to the extent Records Provider discovers that any transferred Patient Records include any identifiable “Patient Health Information,” as such term is defined under the U.S. Health Insurance Portability and Accountability Act of 1996 (“HIPAA”), the Parties shall cooperate in an effort to de-identify the Patient Records consistent with the Safe Harbor approach required by §164.514 of HIPAA. Purinix shall only be entitled to take copies of the Patient Records and, for the avoidance of doubt, nothing in this Agreement shall oblige Records Provider to deliver to Purinix any original documents containing Patient Records.
Patient Privacy. Buyer, as a business associate of Sellers, agrees to comply to the extent applicable with all applicable federal, state and local privacy and security laws, including without limitation the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and all implementing regulations issued pursuant thereto, as may be amended from time to time (45 CFR Parts 160-164). Buyer shall comply with the HIPAA Business Associate Addendum attached hereto as Exhibit B and incorporated herein by reference.
Patient Privacy. Each Party agrees to abide by all applicable Legal Requirements concerning the confidentiality or protection of patient identifiable information and/or patients’ protected health information with respect to patients in Clinical Trials in the NOVACEA Territory, using the Finished Product in the NOVACEA Territory or otherwise involved in the development or commercialization of the Licensed Product or Improvements in the NOVACEA Territory.
Patient Privacy. If the Data Aggregator is a third-party entity, State shall, in accordance with HIPAA, enter into a Business Associate Agreement (“BAA”) with Data Aggregator and abide by all patient privacy requirements under HIPAA.
Patient Privacy. 39. All patient information is governed by the TRIARQ HIPAA Business Associate Agreement which can be found at xxxxx://xxxxxxxxxxxx.xxx/triarq-one-team-care-agreements/ NON-DISPARAGEMENT
Patient Privacy. To the extent applicable to a Contract, the parties hereto agree to comply with the Health Information Technology for Economic and Clinical Health Act of 2009 (the “HITECH ACT”), the Administrative Simplification provisions of the Health Insurance Portability and Accountability Act of 1996, as codified at 42 USC § 1320d through d-8 (“HIPAA”) and any current and future regulations promulgated under either the HITECH Act or HIPAA including without limitation the federal privacy regulations contained in 45 CFR Parts 160 and 164 (the “Federal Privacy Regulations”), the federal security standards contained in 45 CFR Parts 160, 162 and 164 (the “Federal Security Regulations”) and the federal standards for electronic Transactions Regulations”), all as may be amended from time to time, and all collectively referred to herein as “HIPAA Requirements.” The parties further agree not to use or disclose any Protected Health Information (as defined in 45 CFR § 164.501) or Individually Identifiable Health Information (as defined in 42 USC § 1320d), other than as permitted by HIPAA Requirements and the terms of a Contract. The parties agree to enter into any further agreements as necessary to facilitate compliance with HIPAA Requirements.
Patient Privacy. (i) Each of the Company and its Subsidiaries (i) is in compliance in all material respects with all applicable federal, state and local laws and regulations regarding the confidentiality and security of health related information, including, but not limited to the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”), as it may be amended from time to time, and the Health Information Technology for Economic and Clinical Health Act, as incorporated in the American Recovery and Reinvestment Act of 2009 and as it may be amended (the “HITECH Act”) (collectively, “HIPAA”), and the requirements of all regulations thereunder, including without limitation the regulations codified at 45 CFR Parts 160 and 164 and (ii) maintains privacy and security policies, procedures and safeguards that comply in all material respects with all applicable HIPAA requirements and accurately reflect the Company’s and its Subsidiaries’ practices in all material respects.
Patient Privacy. An applicant should not include in reports under this section the names and addresses of individual patients; instead, the applicant should assign a unique code number to each report, preferably not more than eight characters in length. The applicant should include the name of the reporter from whom the information was received. Names of patients, health care professionals, hospitals, and geographical identifiers in adverse drug experience reports are not releasable to the public under FDA's public information regulations in part 20.
